Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
Clinical trial NCT02415413 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02415413
- Sponsor
- PETHEMA Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-07-05
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.